Simon D - Search Results

1

Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy.

Simon D, Kernland Lang K. Simon D, et al. Curr Opin Pediatr. 2011 Dec;23(6):647-52. doi: 10.1097/MOP.0b013e32834cad0a. Curr Opin Pediatr. 2011. PMID: 21970829 Review.

2

Peripheral blood mononuclear cells from IgE- and non-IgE-associated allergic atopic eczema/dermatitis syndrome (AEDS) demonstrate increased capacity of generating interleukin-13 but differ in their potential of synthesizing interferon-gamma.

Simon D, Borelli S, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Allergy. 2002 May;57(5):431-5. doi: 10.1034/j.1398-9995.2002.13506.x. Allergy. 2002. PMID: 11972483

3

The interleukin-13 production by peripheral blood T cells from atopic dermatitis patients does not require CD2 costimulation.

Simon D, Von Gunten S, Borelli S, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Int Arch Allergy Immunol. 2003 Oct;132(2):148-55. doi: 10.1159/000073716. Int Arch Allergy Immunol. 2003. PMID: 14600427

4

Eosinophils and atopic dermatitis.

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Allergy. 2004 Jun;59(6):561-70. doi: 10.1111/j.1398-9995.2004.00476.x. Allergy. 2004. PMID: 15147438 Review.

5

Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.

Simon D, Vassina E, Yousefi S, Kozlowski E, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. J Allergy Clin Immunol. 2004 Oct;114(4):887-95. doi: 10.1016/j.jaci.2004.05.066. J Allergy Clin Immunol. 2004. PMID: 15480330

6

Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.

Simon D, Vassina E, Yousefi S, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Allergy. 2005 Jul;60(7):944-51. doi: 10.1111/j.1398-9995.2005.00798.x. Allergy. 2005. PMID: 15932386

7

Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis.

Vassina E, Leverkus M, Yousefi S, Braathen LR, Simon HU, Simon D. Vassina E, et al. Among authors: simon hu, simon d. J Invest Dermatol. 2005 Oct;125(4):746-52. doi: 10.1111/j.0022-202X.2005.23878.x. J Invest Dermatol. 2005. PMID: 16185275 Free article.

8

Anti-interleukin-5 antibody therapy in eosinophilic diseases.

Simon D, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Pathobiology. 2005;72(6):287-92. doi: 10.1159/000091326. Pathobiology. 2005. PMID: 16582580 Review.

9

Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.

Simon D, Lindberg RL, Kozlowski E, Braathen LR, Simon HU. Simon D, et al. Among authors: simon hu. Exp Dermatol. 2006 Jun;15(6):441-6. doi: 10.1111/j.0906-6705.2006.00428.x. Exp Dermatol. 2006. PMID: 16689860

10

Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort.

Simon D, Lübbe J, Wüthrich B, Wiesner A, Weber MM, Laffitte E, Anliker MD, Schöni MH, Braathen LR, Schmid-Grendelmeier P, Gilgen Bobalj N, Schneider D. Simon D, et al. Dermatology. 2006;213(4):313-8. doi: 10.1159/000096195. Dermatology. 2006. PMID: 17135737 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,565 results

Search Page

Filters